ResMed Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference
06 January 2021 - 1:00AM
Business Wire
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief
executive officer, will present at the 39th Annual J.P. Morgan
Healthcare Conference on Tuesday, January 12, 2021, beginning at
approximately 4:30 p.m. (Eastern Standard Time) via webcast.
More information about this event, including access to the live,
audio-only webcast, may be accessed by visiting
http://investor.resmed.com. Conference attendees will be able to
access the video webcast via the J.P. Morgan Digital Conference
Book. The audio-only webcast replay will be available approximately
one hour after the live webcast ends and will be accessible for
approximately 30 days following the conference.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions
that treat and keep people out of the hospital, empowering them to
live healthier, higher-quality lives. Our digital health
technologies and cloud-connected medical devices transform care for
people with sleep apnea, COPD, and other chronic diseases. Our
comprehensive out-of-hospital software platforms support the
professionals and caregivers who help people stay healthy in the
home or care setting of their choice. By enabling better care, we
improve quality of life, reduce the impact of chronic disease, and
lower costs for consumers and healthcare systems in more than 140
countries. To learn more, visit ResMed.com and follow @ResMed.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210105005330/en/
For investors Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
For media Jayme Rubenstein +1 858.836.6798
news@resmed.com
Resmed (ASX:RMD)
Historical Stock Chart
From Oct 2024 to Nov 2024
Resmed (ASX:RMD)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Resmed Inc (Australian Stock Exchange): 0 recent articles
More Resmed Cdi 10:1 News Articles